A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia: response to Goldberg et al.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples